The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(R)-8-(1,2-Dihydroxyethyl)-9-ethyl-6,6-dimethyl-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile ID: ALA3746402
PubChem CID: 127042842
Max Phase: Preclinical
Molecular Formula: C23H22N2O3
Molecular Weight: 374.44
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: CCc1cc2c(cc1[C@@H](O)CO)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O
Standard InChI: InChI=1S/C23H22N2O3/c1-4-13-8-16-17(9-15(13)19(27)11-26)23(2,3)22-20(21(16)28)14-6-5-12(10-24)7-18(14)25-22/h5-9,19,25-27H,4,11H2,1-3H3/t19-/m0/s1
Standard InChI Key: CHXRVSLZMGBYAR-IBGZPJMESA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
0.0000 -0.3300 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.2600 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5200 -0.3300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8000 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8000 1.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5200 2.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2600 1.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2800 1.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5200 2.6000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7800 1.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7800 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5200 -0.3300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2800 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0500 2.5700 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3600 1.8600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3600 0.4000 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0500 -0.3600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5159 3.8000 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.5712 -0.9087 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4649 -0.9017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6520 2.6236 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6406 3.8235 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.0802 -0.3506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.1194 -0.9505 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.6665 -0.3389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6812 -1.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7001 0.2709 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.7259 -2.4301 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 1 0
2 7 2 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
8 13 2 0
1 13 1 0
14 15 1 0
15 16 2 0
16 17 1 0
4 17 2 0
5 14 2 0
6 18 2 0
3 19 1 0
3 20 1 0
21 22 1 0
15 21 1 0
23 24 3 0
11 23 1 0
16 25 1 0
25 26 1 0
25 27 1 1
26 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 374.44Molecular Weight (Monoisotopic): 374.1630AlogP: 3.50#Rotatable Bonds: 3Polar Surface Area: 97.11Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 12.15CX Basic pKa: ┄CX LogP: 3.57CX LogD: 3.57Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.65Np Likeness Score: 0.73
References 1. Hatcher JM, Bahcall M, Choi HG, Gao Y, Sim T, George R, Jänne PA, Gray NS.. (2015) Discovery of Inhibitors That Overcome the G1202R Anaplastic Lymphoma Kinase Resistance Mutation., 58 (23): [PMID:26568289 ] [10.1021/acs.jmedchem.5b01136 ]